Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Aorta01:14

The Aorta

4.2K
The aorta is the largest artery in the human body. It originates from the left ventricle of the heart and extends down to the abdomen, where it splits into two smaller arteries. Structurally, it can be divided into four main parts: the ascending aorta, the aortic arch, the thoracic aorta, and the abdominal aorta.
The average diameter of the aorta is approximately 2-3 cm, but the size can vary depending on the section of the aorta and the individual's age, sex, and body size. The aorta is...
4.2K
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

1.6K
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.6K
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

1.2K
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.2K
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

650
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
650
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

589
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
589
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

478
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
478

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Exact Match Outcome Analysis of Two Different Patches During Femoral Endarterectomy.

World journal of surgery·2026
Same author

Single-stage repair for acute type A aortic dissection complicated by rupture of the infrarenal aorta.

JTCVS structural and endovascular·2026
Same author

Endovascular repair of diseases originating in the ascending thoracic aorta: A systematic review and meta-analysis.

JTCVS structural and endovascular·2026
Same author

The through-and-through wire rescue: A simple intraoperative bailout strategy for false lumen frozen elephant trunk deployment.

JTCVS techniques·2026
Same author

Multimodal Endovascular Treatment of Post-Dissection Thoracoabdominal Aneurysm Using Adjunctive Advanced Endovascular Techniques Combined to Branched Repair: Case Report.

Reports (MDPI)·2026
Same author

International Union of Angiology (IUA) Consensus Document on Enhanced Recovery after Surgery (ERAS) in Vascular Surgery.

International angiology : a journal of the International Union of Angiology·2026

Related Experiment Video

Updated: May 5, 2026

Isolation and Excision of Murine Aorta; A Versatile Technique in the Study of Cardiovascular Disease
07:25

Isolation and Excision of Murine Aorta; A Versatile Technique in the Study of Cardiovascular Disease

Published on: November 24, 2014

32.4K

Time is Aorta in Uncomplicated Type B Aortic Dissection.

Efrem Civilini1, Maria Giulia Pascucci1, Matti Jubouri2

  • 1Vascular Surgery - Department of Biomedical Sciences, IRCCS Humanitas University Hospital, Rozzano, Italy.

Annals of Vascular Surgery
|February 1, 2025
PubMed
Summary

The subacute phase (14-90 days) is the optimal time for thoracic endovascular aortic repair (TEVAR) in uncomplicated type B aortic dissection (uTBAD), balancing safety and efficacy. Early or late TEVAR may lead to increased risks and poorer outcomes.

More Related Videos

Author Spotlight: Using Point-of-Care Ultrasound for Comprehensive Evaluation of the Abdominal Aorta
07:12

Author Spotlight: Using Point-of-Care Ultrasound for Comprehensive Evaluation of the Abdominal Aorta

Published on: September 8, 2023

2.2K
Novel and Innovative Hybrid Technique for Type A Aortic Dissection
06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

186

Related Experiment Videos

Last Updated: May 5, 2026

Isolation and Excision of Murine Aorta; A Versatile Technique in the Study of Cardiovascular Disease
07:25

Isolation and Excision of Murine Aorta; A Versatile Technique in the Study of Cardiovascular Disease

Published on: November 24, 2014

32.4K
Author Spotlight: Using Point-of-Care Ultrasound for Comprehensive Evaluation of the Abdominal Aorta
07:12

Author Spotlight: Using Point-of-Care Ultrasound for Comprehensive Evaluation of the Abdominal Aorta

Published on: September 8, 2023

2.2K
Novel and Innovative Hybrid Technique for Type A Aortic Dissection
06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

186

Area of Science:

  • Cardiovascular Surgery
  • Vascular Medicine
  • Medical Device Technology

Background:

  • Best medical therapy is standard for uncomplicated type B aortic dissection (uTBAD).
  • Thoracic endovascular aortic repair (TEVAR) shows promise for aortic remodeling and long-term outcomes.
  • Optimal timing for TEVAR in uTBAD is debated.

Purpose of the Study:

  • To evaluate the safety, efficacy, and outcomes of TEVAR at different time points in uTBAD.
  • To determine the optimal therapeutic window for TEVAR in uTBAD.

Main Methods:

  • Comprehensive literature review of PubMed and Scopus.
  • Synthesis of research evidence on TEVAR timing in uTBAD.

Main Results:

  • Hyperacute TEVAR (<24 hours) has prohibitive risks.
  • Acute TEVAR (1-14 days) offers remodeling benefits but has high complication rates.
  • Subacute TEVAR (14-90 days) provides the best balance of safety and efficacy, with superior outcomes.
  • Chronic TEVAR (>90 days) is associated with poorer outcomes and limited remodeling.

Conclusions:

  • The subacute phase (14-90 days) is the optimal window for TEVAR in uTBAD.
  • This timing offers reduced procedural risks and favorable long-term results.
  • Further research is needed to refine TEVAR timing strategies.